Literature DB >> 6313185

Cerebrospinal fluid GABA as an index of brain GABA activity.

J Grove, M G Palfreyman, P J Schechter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6313185     DOI： 10.1097/00002826-198309000-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  12 in total

Review 1.  Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.

Authors:  P J Schechter; A Sjoerdsma
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

Review 2.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.

Authors:  E Ben-Menachem; L I Persson; P J Schechter; K D Haegele; N Huebert; J Hardenberg; L Dahlgren; J P Mumford
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 4.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 5.  Clinical pharmacology of vigabatrin.

Authors:  P J Schechter
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

6.  Amino acid levels in human CSF after generalized seizure.

Authors:  A Pitkänen; P J Riekkinen; T Halonen; A Ylinen; T Ruutiainen; M Lehtinen
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  Cerebrospinal fluid concentrations of free GABA in schizophrenia: no changes after haloperidol treatment.

Authors:  W F Gattaz; E Roberts; H Beckmann
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

8.  Cerebrospinal fluid GABA and seizure control with vigabatrin.

Authors:  P J Riekkinen; A Ylinen; T Halonen; J Sivenius; A Pitkanen
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

9.  Vigabatrin in epilepsy in mentally retarded patients.

Authors:  R Matilainen; A Pitkänen; T Ruutiainen; E Mervaala; P Riekkinen
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

10.  Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Halonen; R Kutvonen; P Hartikainen; P Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.